MedTrace Logo

Comparison of Two Daily Disposable Soft Contact Lenses

NCT03779503 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2020-10-08

Study results available
· View outcomes & findings →

Summary

The aim of this study was to investigate the short-term clinical performance and subjective acceptance of the two study lenses.

Conditions

  • Astigmatism Bilateral

Interventions

DEVICE

midafilcon A

midafilcon A 1 day daily disposable contact lens

DEVICE

somofilcon A

somofilcon A 1 day daily disposable contact lens

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • Philip Morgan, PhD MCOptom FAAO FBCLA · Eurolens Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-08
Primary Completion
2019-07-30
Completion
2019-09-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03779503 on ClinicalTrials.gov